Global law firm Freshfields advised Materialise NV on the listing of its ordinary shares on Euronext Brussels as of November 20th 2025. Prior to the Brussels listing, Materialise was already publicly traded on the Nasdaq through American depositary shares (ADSs) representing its ordinary shares. With the admission to trading on Euronext Brussels, Materialise now has a dual-listing structure.
Materialise NV is a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services. Headquartered in Belgium and with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the world's largest and most complete 3D printing facilities.
Freshfields advised on key aspects of the transaction, including the drafting of the prospectus, coordination of the listing process, and any governance and post-listing compliance matters of the company. KBC Securities acted as listing agent for Materialise’s Euronext Brussels admission.
The Freshfields team was led by partner Deborah Janssens, counsel Sigrid Ververken, and associates Riet Devriendt and Emma Heijmans. The team further included counsel Nikolaas Van Robbroeck and associate Bo Debreuck, who advised on tax aspects.
